Shepherd J - Search Results

1

Shepherd J, Packard CJ. Shepherd J, et al. Isr J Med Sci. 1996 Jun;32(6):345-55. Isr J Med Sci. 1996. PMID: 8682639 Review. No abstract available.

2

Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS).

Streja L, Packard CJ, Shepherd J, Cobbe S, Ford I; WOSCOPS Group. Streja L, et al. Among authors: shepherd j. Am J Cardiol. 2002 Oct 1;90(7):731-6. doi: 10.1016/s0002-9149(02)02599-7. Am J Cardiol. 2002. PMID: 12356386

3

Affairs of the heart: cholesterol and coronary heart disease risk.

Shepherd J, Gaffney D, Packard CJ. Shepherd J, et al. Dis Markers. 1991 Mar-Apr;9(2):63-71. Dis Markers. 1991. PMID: 1782746 Review. No abstract available.

4

Postprandial lipemia, fenofibrate and coronary artery disease.

Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J. Simpson HS, et al. Among authors: shepherd j. Atherosclerosis. 1990 Dec;85(2-3):193-202. doi: 10.1016/0021-9150(90)90111-u. Atherosclerosis. 1990. PMID: 2102083

5

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Shepherd J, et al. N Engl J Med. 1995 Nov 16;333(20):1301-7. doi: 10.1056/NEJM199511163332001. N Engl J Med. 1995. PMID: 7566020 Free article. Clinical Trial.

6

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.

Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Griffin BA, et al. Among authors: shepherd j. Atherosclerosis. 1994 Apr;106(2):241-53. doi: 10.1016/0021-9150(94)90129-5. Atherosclerosis. 1994. PMID: 8060384

7

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N. Wallace AM, et al. Among authors: shepherd j. Circulation. 2001 Dec 18;104(25):3052-6. doi: 10.1161/hc5001.101061. Circulation. 2001. PMID: 11748099

8

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.

Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, Packard CJ, Caslake MJ. Forster LF, et al. Among authors: shepherd j. Atherosclerosis. 2002 Sep;164(1):129-45. doi: 10.1016/s0021-9150(02)00052-7. Atherosclerosis. 2002. PMID: 12119202 Clinical Trial.

9

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Shepherd J, et al. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x. Lancet. 2002. PMID: 12457784 Clinical Trial.

10

Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome.

Warwick GL, Packard CJ, Murray L, Grierson D, Stewart JP, Shepherd J, Boulton-Jones JM. Warwick GL, et al. Among authors: shepherd j. Clin Sci (Lond). 1992 Jun;82(6):701-8. doi: 10.1042/cs0820701. Clin Sci (Lond). 1992. PMID: 1320552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,010 results

Search Page

Filters